Sage Journals: Discover world-class research

Abstract

French

Background:

Topical 5% 5-fluorouracil (5-FU) is known to cause toxicity, such as erythema, pain, and crusting/erosions.

Objectives:

We sought to develop a scale to measure this toxicity and test the scale for reliability.

Methods:

A scale was developed involving four parameters: erythema severity, percentage of face involved in erythema, crusting/erosions severity, and percentage of face involved in crusting/erosions. Thirteen raters graded 99 sets of photographs from the Veterans Affairs Keratinocyte Carcinoma Chemoprevention (VAKCC) Trial using these parameters.

Results:

Intraclass correlation overall for 13 raters was 0.82 (95% CI 0.77–0.86). There was no statistically significant trend in reliability by level of training in dermatology.

Conclusions:

This scale is a reliable method of evaluating the severity of toxicity from topical 5-fluorouracil and can be used by dermatologists and nondermatologists alike.

Get full access to this article

View all access options for this article.

References

Weinstock

Bingham

Digiovanna

. Tretinoin and the prevention of keratinocyte carcinoma (basal and squamous cell carcinoma of the skin): a Veterans Affairs randomized chemoprevention trial. J Invest Dermatol 2012;132:1583–90, doi:10.1038/jid.2011.483.

Korman

Moy

Ling

. Dosing with 5% imiquimod cream 3 times per week for the treatment of actinic keratosis: results of two phase 3, randomized, double-blind, parallel-group, vehicle-controlled trials. Arch Dermatol 2005;141:467–73, doi:10.1001/archderm.141.4.467.

Lebwohl

Swanson

Anderson

. Ingenol mebutate gel for actinic keratosis. N Engl J Med 2012;366:1010–9, doi:10.1056/NEJMoa1111170.

Stockfleth

Meyer

Benninghoff

. A randomized, double-blind, vehicle-controlled study to assess 5% imiquimod cream for the treatment of multiple actinic keratoses. Arch Dermatol 2002;138:1498–502, doi:10.1001/archderm.138.11.1498.

Gross

Kircik

Kricorian

. 5% 5-Fluorouracil cream for the treatment of small superficial basal cell carcinoma: efficacy, tolerability, cosmetic outcome, and patient satisfaction. Dermatol Surg 2007;33:433–9; discussion 40, doi:10.1111/j.1524-4725.2007.33090.x.

Cochran

. Sampling techniques. 3rd ed. New York: John Wiley & Sons; 1977.

Shrout

Fleiss

. Intraclass correlations: uses in assessing rater reliability. Psychol Bull 1979;86:420–8, doi:10.1037/0033-2909.86.2.420.

Morton

Horn

Leman

. Comparison of topical methyl aminolevulinate photodynamic therapy with cryotherapy or fluorouracil for treatment of squamous cell carcinoma in situ: results of a multicenter randomized trial. Arch Dermatol 2006;142:729–35, doi:10.1001/archderm.142.6.729.

Salim

Leman

McColl

. Randomized comparison of photodynamic therapy with topical 5-fluorouracil in Bowen's disease. Br J Dermatol 2003;148:539–43, doi:10.1046/j.1365-2133.2003.05033.x.

10.

Love

Bernhard

Bordeaux

. Topical imiquimod or fluorouracil therapy for basal and squamous cell carcinoma: a systematic review. Arch Dermatol 2009;145:1431–8, doi:10.1001/archdermatol.2009.291.

11.

Portney

Watkins

. Foundations of clinical research: applications to practice. 3rd ed. Old Tappan, NJ: Pearson Education; 2009.

12.

Stough

Bucko

Vamvakias

. Fluorouracil cream 0.5% for actinic keratoses on multiple body sites: an 18-month open-label study. Cutis 2010;85:267–73.

13.

Jorizzo

Stewart

Bucko

. Randomized trial evaluating a new 0.5% fluorouracil formulation demonstrates efficacy after 1-, 2-, or 4-week treatment in patients with actinic keratosis. Cutis 2002;70:335–9.

14.

Weiss

Menter

Hevia

. Effective treatment of actinic keratosis with 0.5% fluorouracil cream for 1, 2, or 4 weeks. Cutis 2002;70:22–9.

15.

Jorizzo

Dinehart

Matheson

. Vehicle-controlled, double-blind, randomized study of imiquimod 5% cream applied 3 days per week in one or two courses of treatment for actinic keratoses on the head. J Am Acad Dermatol 2007;57:265–8, doi:10.1016/j.jaad.2007.01.047.

16.

Zeichner

Stern

Uliasz

. Placebo-controlled, double-blind, randomized pilot study of imiquimod 5% cream applied once per week for 6 months for the treatment of actinic keratoses. J Am Acad Dermatol 2009;60:59–62, doi:10.1016/j.jaad.2008.08.039.

17.

Wolf

Jr Taylor

Tschen

Kang

. Topical 3.0% diclofenac in 2.5% hyaluronan gel in the treatment of actinic keratoses. Int J Dermatol 2001;40:709–13, doi:10.1046/j.1365-4362.2001.01324.x.

Measuring the Severity of Topical 5-Fluorouracil Toxicity